Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang, Qian, Matuozzo, Daniela, Le Pen, Jérémie, Lee, Danyel, Moens, Leen, Asano, Takaki, Bohlen, Jonathan, Liu, Zhiyong, Moncada-Velez, Marcela, Kendir-Demirkol, Yasemin, Jing, Huie, Bizien, Lucy, Marchal, Astrid, Abolhassani, Hassan, Delafontaine, Selket, Bucciol, Giorgia, Bayhan, Gulsum Ical, Keles, Sevgi, Kiykim, Ayca, Hancerli, Selda, Haerynck, Filomeen, Florkin, Benoit, Hatipoglu, Nevin, Ozcelik, Tayfun, Morelle, Guillaume, Zatz, Mayana, Ng, Lisa F. P., Lye, David C., Young, Barnaby Edward, Leo, Yee Sin, Dalgard, Clifton L., Lifton, Richard P., Renia, Laurent, Meyts, Isabelle, Jouanguy, Emmanuelle, Hammarström, Lennart, Pan-Hammarström, Qiang, Boisson, Bertrand, Bastard, Paul, Su, Helen C., Boisson-Dupuis, Stéphanie, Abel, Laurent, Rice, Charles M., Zhang, Shen-Ying, Cobat, Aurélie, Casanova, Jean-Laurent
Other Authors: School of Biological Sciences
Format: Article
Language:English
Published: 2022
Subjects:
Online Access:https://hdl.handle.net/10356/163940
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-163940
record_format dspace
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Pyogenic Bacterial-Infections
Simplex-Virus Encephalitis
spellingShingle Science::Medicine
Pyogenic Bacterial-Infections
Simplex-Virus Encephalitis
Zhang, Qian
Matuozzo, Daniela
Le Pen, Jérémie
Lee, Danyel
Moens, Leen
Asano, Takaki
Bohlen, Jonathan
Liu, Zhiyong
Moncada-Velez, Marcela
Kendir-Demirkol, Yasemin
Jing, Huie
Bizien, Lucy
Marchal, Astrid
Abolhassani, Hassan
Delafontaine, Selket
Bucciol, Giorgia
Bayhan, Gulsum Ical
Keles, Sevgi
Kiykim, Ayca
Hancerli, Selda
Haerynck, Filomeen
Florkin, Benoit
Hatipoglu, Nevin
Ozcelik, Tayfun
Morelle, Guillaume
Zatz, Mayana
Ng, Lisa F. P.
Lye, David C.
Young, Barnaby Edward
Leo, Yee Sin
Dalgard, Clifton L.
Lifton, Richard P.
Renia, Laurent
Meyts, Isabelle
Jouanguy, Emmanuelle
Hammarström, Lennart
Pan-Hammarström, Qiang
Boisson, Bertrand
Bastard, Paul
Su, Helen C.
Boisson-Dupuis, Stéphanie
Abel, Laurent
Rice, Charles M.
Zhang, Shen-Ying
Cobat, Aurélie
Casanova, Jean-Laurent
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
description Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5-13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10-11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Zhang, Qian
Matuozzo, Daniela
Le Pen, Jérémie
Lee, Danyel
Moens, Leen
Asano, Takaki
Bohlen, Jonathan
Liu, Zhiyong
Moncada-Velez, Marcela
Kendir-Demirkol, Yasemin
Jing, Huie
Bizien, Lucy
Marchal, Astrid
Abolhassani, Hassan
Delafontaine, Selket
Bucciol, Giorgia
Bayhan, Gulsum Ical
Keles, Sevgi
Kiykim, Ayca
Hancerli, Selda
Haerynck, Filomeen
Florkin, Benoit
Hatipoglu, Nevin
Ozcelik, Tayfun
Morelle, Guillaume
Zatz, Mayana
Ng, Lisa F. P.
Lye, David C.
Young, Barnaby Edward
Leo, Yee Sin
Dalgard, Clifton L.
Lifton, Richard P.
Renia, Laurent
Meyts, Isabelle
Jouanguy, Emmanuelle
Hammarström, Lennart
Pan-Hammarström, Qiang
Boisson, Bertrand
Bastard, Paul
Su, Helen C.
Boisson-Dupuis, Stéphanie
Abel, Laurent
Rice, Charles M.
Zhang, Shen-Ying
Cobat, Aurélie
Casanova, Jean-Laurent
format Article
author Zhang, Qian
Matuozzo, Daniela
Le Pen, Jérémie
Lee, Danyel
Moens, Leen
Asano, Takaki
Bohlen, Jonathan
Liu, Zhiyong
Moncada-Velez, Marcela
Kendir-Demirkol, Yasemin
Jing, Huie
Bizien, Lucy
Marchal, Astrid
Abolhassani, Hassan
Delafontaine, Selket
Bucciol, Giorgia
Bayhan, Gulsum Ical
Keles, Sevgi
Kiykim, Ayca
Hancerli, Selda
Haerynck, Filomeen
Florkin, Benoit
Hatipoglu, Nevin
Ozcelik, Tayfun
Morelle, Guillaume
Zatz, Mayana
Ng, Lisa F. P.
Lye, David C.
Young, Barnaby Edward
Leo, Yee Sin
Dalgard, Clifton L.
Lifton, Richard P.
Renia, Laurent
Meyts, Isabelle
Jouanguy, Emmanuelle
Hammarström, Lennart
Pan-Hammarström, Qiang
Boisson, Bertrand
Bastard, Paul
Su, Helen C.
Boisson-Dupuis, Stéphanie
Abel, Laurent
Rice, Charles M.
Zhang, Shen-Ying
Cobat, Aurélie
Casanova, Jean-Laurent
author_sort Zhang, Qian
title Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
title_short Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
title_full Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
title_fullStr Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
title_full_unstemmed Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
title_sort recessive inborn errors of type i ifn immunity in children with covid-19 pneumonia
publishDate 2022
url https://hdl.handle.net/10356/163940
_version_ 1759854293602533376
spelling sg-ntu-dr.10356-1639402023-02-28T17:10:35Z Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia Zhang, Qian Matuozzo, Daniela Le Pen, Jérémie Lee, Danyel Moens, Leen Asano, Takaki Bohlen, Jonathan Liu, Zhiyong Moncada-Velez, Marcela Kendir-Demirkol, Yasemin Jing, Huie Bizien, Lucy Marchal, Astrid Abolhassani, Hassan Delafontaine, Selket Bucciol, Giorgia Bayhan, Gulsum Ical Keles, Sevgi Kiykim, Ayca Hancerli, Selda Haerynck, Filomeen Florkin, Benoit Hatipoglu, Nevin Ozcelik, Tayfun Morelle, Guillaume Zatz, Mayana Ng, Lisa F. P. Lye, David C. Young, Barnaby Edward Leo, Yee Sin Dalgard, Clifton L. Lifton, Richard P. Renia, Laurent Meyts, Isabelle Jouanguy, Emmanuelle Hammarström, Lennart Pan-Hammarström, Qiang Boisson, Bertrand Bastard, Paul Su, Helen C. Boisson-Dupuis, Stéphanie Abel, Laurent Rice, Charles M. Zhang, Shen-Ying Cobat, Aurélie Casanova, Jean-Laurent School of Biological Sciences Lee Kong Chian School of Medicine (LKCMedicine) A*STAR Infectious Diseases Labs National Centre for Infectious Diseases National University of Singapore Tan Tock Seng Hospital Science::Medicine Pyogenic Bacterial-Infections Simplex-Virus Encephalitis Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5-13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10-11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children. Agency for Science, Technology and Research (A*STAR) National Medical Research Council (NMRC) Published version The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute; the Rockefeller University; the St. Giles Foundation; the National Institutes of Health (NIH; R01AI088364 and R01AI63029); the National Center for Advancing Translational Sciences; NIH Clinical and Translational Science Award program (UL1 TR001866); a Fast Grant from Emergent Ventures; the Mercatus Center at George Mason University; the Yale Center for Mendelian Genomics; the GSP Coordinating Center funded by the National Human Genome Research Institute (UM1HG006504 and U24HG008956); the Yale High Performance Computing Center (S10OD018521); the Fisher Center for Alzheimer’s Research Foundation; the JPB Foundation; the Meyer Foundation; the French National Research Agency (ANR) under the “Investments for the Future” program (ANR-10-IAHU-01); the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID); the French Foundation for Medical Research (EQU201903007798); the ANR GenMISC (ANR21-COVR-039) ANRS-COV05, ANR GENVIR (ANR-20-CE93-003), and ANR AABIFNCOV (ANR-20-CO11-0001) projects; the European Union’s Horizon 2020 research and innovation program under grant agreement no. 824110 (EASI-genomics); the Square Foundation; Grandir—Fonds de solidarite pour l ´ ’enfance; Fondation du Souffle; the SCOR Corporate Foundation for Science; The French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19); Institut National de la Sante et de la Recher- ´ che Medicale (INSERM); REACTing-INSERM; and the University of Paris. Work in the Laboratory of Virology and Infectious Disease was supported by NIH grants P01AI138398-S1, 2U19AI111825, R01AI091707-10S1, and R01AI161444; a George Mason University Fast Grant; the G. Harold and Leila Y. Mathers Charitable Foundation; the Meyer Foundation; and the Bawd Foundation. J. Le Pen was supported by the Francois Wallace Monahan Postdoctoral Fellowship at The Rockefeller University and the European Molecular Biology Organization Long-Term Fellowship (ALTF 380- 2018). P. Bastard was supported by the MD-PhD program of the Imagine Institute (with the support of the Fondation BettencourtSchueller). H.C. Su and H. Jing are supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH. G. Novelli and A. Novelli from the COVID Human Genetic Effort are supported by Regione Lazio (Research Group Projects 2020) no. A0375-2020-36663, GecoBiomark. I. Meyts is a Senior Clinical Investigator at the Research Foundation—Flanders and is supported by the CSL Behring Chair of Primary Immunodeficiencies, by the CSL-Behring Research Grant, by the KU Leuven C1 grant C16/18/007, by a VIB GC PID grant, by the FWO grants G0C8517N, G0B5120N, and G0E8420N and by the Jeffrey Modell Foundation. This project has received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 948959). This work is supported by ERN-RITA. S. Delafontaine is supported by personal FWO grant 11F4421N. L. Renia and L.F.P. Ng were supported by the Singapore National Medical Research Council COVID-19 Research Fund (COVID19RF001; COVID19RF-0008; COVID19RF-060) and A*STAR COVID-19 research funding (H/20/04/g1/006). The Canarian Sequencing Hub is funded by Instituto de Salud Carlos III (COV20_01333 and COV20_01334), the Spanish Ministry of Science and Innovation (RTC-2017-6471-1; AEI/FEDER, UE), and Cabildo Insular de Tenerife (CGIEU0000219140 and “Apuestas cient´ıficas del ITER para colaborar en la lucha contra la COVID-19”). 2022-12-22T08:02:54Z 2022-12-22T08:02:54Z 2022 Journal Article Zhang, Q., Matuozzo, D., Le Pen, J., Lee, D., Moens, L., Asano, T., Bohlen, J., Liu, Z., Moncada-Velez, M., Kendir-Demirkol, Y., Jing, H., Bizien, L., Marchal, A., Abolhassani, H., Delafontaine, S., Bucciol, G., Bayhan, G. I., Keles, S., Kiykim, A., ...Casanova, J. (2022). Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. Journal of Experimental Medicine, 219(8), e20220131-. https://dx.doi.org/10.1084/jem.20220131 0022-1007 https://hdl.handle.net/10356/163940 10.1084/jem.20220131 35708626 2-s2.0-85136173099 8 219 e20220131 en COVID19RF-001 COVID19RF-0008 COVID19RF-060 H/20/04/g1/006 Journal of Experimental Medicine © 2022 Zhang et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/) application/pdf